Michael Freissmuth

City:

Vienna

Country:

Austria

Published Applications:

Last publication date:

2018-01-11

Top Assignees for applications by Michael Freissmuth

The entities that hold a legal rights for patent applications filed by inventor Freissmuth Michael:

SCIPHARM SÀRL 1 Luxembourg, Luxembourg
IGENEON KREBS-IMMNUTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG 1 Vienna, Austria
SciPharm S.à.r.l 1 Mertert, Luxembourg
Axentis Pharma AG 1 Wangen, Switzerland
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG 1 Vienna, Austria
SciPharm SàRL 1 Luxembourg, Luxembourg
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS- UND ENTWICKLUNGS-AG 1 Wien, Austria
BIODEVELOPS PHARMA ENTWICKLUNG GMBH 1 Wien, Austria
SciPharm SaRL 1 Junglinster, Luxembourg

Recent patent applications by Freissmuth Michael

Michael Freissmuth from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-01-11

US20180008606A1

Human necessities

Composition for use in increasing engraftment efficacy of haematopoetic stem cells after transplantation

#2 | 2016-06-23

US20160175319A1

Human necessities

Composition for the treatment of cystic fibrosis

#3 | 2014-01-16

US20140018430A1

Human necessities

Composition for the treatment of cystic fibrosis

#4 | 2013-12-26

US20130344038A1

Human necessities

Method for enhancing engraftment of haematopoetic stem cells

#5 | 2010-05-27

US20100129343A1

Human necessities

Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface

#6 | 2009-07-16

US20090181030A1

Chemistry; metallurgy

USE OF A PREPARATION BASED ON AN ANTIBODY DIRECTED AGAINST A TUMOR-ASSOCIATED GLYCOSYLATION

#7 | 2009-01-15

US20090017006A1

Human necessities

USE OF A COMPOUND FOR ENHANCING THE EXPRESSION OF MEMBRANE PROTEINS ON THE CELL SURFACE

#8 | 2007-09-20

US20070218043A1

Human necessities

Use of a compound for enhancing the expression of membrane proteins on the cell surface

#9 | 2006-01-12

US20060008454A1

Human necessities

Use of a compound for enhancing the expression of membrane proteins on the cell surface

#10 | 2005-10-13

US20050226880A1

Chemistry; metallurgy

Use of a preparation based on an antibody directed against a tumor-associated glycosylation

InventorID:

3792844 ⎘